FDA warns four companies it says are marketing unapproved copies of popular weight loss drugs.
FDA publishes an updated Global Unique Device Identification Database guidance.
FDA approves Hikmas liraglutide injection, the first generic form of Novo Nordisks Victoza it has approved.
FDA approves an expanded indication for Rhythms Imcivree to include pediatric patients as young as age 2.
FDA approves Ionis Tryngolza as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome.
FDA says it has completed its evaluation of several adverse effects found in dogs treated with Librela for pain associated with osteoarthritis.
FDA approves Novo Nordisks Alhemo as a prophylaxis for some hemophilia patients.
FDA approves a new indication for Lillys Zepbound to treat some obese patients with obstructive sleep apnea.
